Brooklyn Filmmaker Spotlights Struggles And Triumphs of Teen With Sickle Cell Disease
Keenan 'Special' Bristol's film highlights the struggles of those with sickle cell disease and the need for compatible blood donations.
'Giving blood is important and costs nothing'
Blood donations in London have significantly dropped post-December, impacting availability for critical blood types, especially among communities needing specific support.
Brooklyn Filmmaker Spotlights Struggles And Triumphs of Teen With Sickle Cell Disease
Keenan 'Special' Bristol's film highlights the struggles of those with sickle cell disease and the need for compatible blood donations.
'Giving blood is important and costs nothing'
Blood donations in London have significantly dropped post-December, impacting availability for critical blood types, especially among communities needing specific support.
CRISPR genome-editing grows up: advanced therapies head for the clinic
Gene-editing therapies like Casgevy show long-lasting benefits for blood disorders but face challenges in accessibility due to complexity and cost.
The World's First Crispr Drug Gets a Slow Start
Casgevy is the first approved CRISPR gene-editing treatment available, but complexities hinder widespread patient access.
The First Crispr Treatment Is Making Its Way to Patients
The first CRISPR-based treatment, Casgevy, has been approved for sickle cell disease and beta thalassemia, marking a significant advance in gene-editing therapies.
CRISPR genome-editing grows up: advanced therapies head for the clinic
Gene-editing therapies like Casgevy show long-lasting benefits for blood disorders but face challenges in accessibility due to complexity and cost.
The World's First Crispr Drug Gets a Slow Start
Casgevy is the first approved CRISPR gene-editing treatment available, but complexities hinder widespread patient access.
The First Crispr Treatment Is Making Its Way to Patients
The first CRISPR-based treatment, Casgevy, has been approved for sickle cell disease and beta thalassemia, marking a significant advance in gene-editing therapies.
Sickle cell disease is caused by a point mutation in the HBB gene that impacts hemoglobin function and structure.
Meet the Advocates and Researchers Revolutionizing Sickle Cell Care
Widespread newborn screening is essential to combat sickle cell disease effectively in Nigeria.
New Sickle Cell Treatments Reach Patients after Years of Effort
Sickle cell disease is complicated, affecting treatment despite a single genetic cause.
Research is multifaceted, targeting multiple levels to address the disease's complexity.
Doctors cured her sickle-cell disease. So why is she still in pain?
Genesis Jones underwent a stem cell transplant to cure her sickle-cell disease, but continues to face significant health challenges and isolation post-treatment.
Innovative Thinking Could Make New Sickle Cell Treatments More Accessible
Gene therapies for sickle cell disease offer hope for functional cure, but high costs and accessibility challenges remain.
Life-changing' sickle cell drug approved for NHS roll-out after patient-led campaign
Successful patient-led appeal leads to new sickle cell treatment recommendation by NICE in the UK.
The Fight to Pay for Gene Therapy
Sickle-cell disease causes inflammation, pain, and blocked blood flow due to misshapen red blood cells.
Racism and lack of empathy in healthcare pose barriers to adequate pain management for sickle-cell patients.
New Queen's Hospital machine for disease that 'affects every aspect of life'
Spectra Optia Apheresis system benefits sickle cell patients by reducing transfusions and managing pain.
Raising awareness about sickle cell, antenatal screening, and treatments like red cell exchange are crucial for effective management.
Former Patriot Devin McCourty honored as 'Hero Among Us' at Celtics game
Devin McCourty, former Patriots safety, was honored with the Celtics' 'Hero Among Us' award for his work in the community.
McCourty and his twin brother co-founded 'Tackle Sickle Cell' over 10 years ago to raise awareness for the disease and have raised over $1.2 million for Boston Medical Center.
'I hope new test will change lives of rare blood disease sufferers like me'
Genetic test for sickle cell disease rolled out across NHS
Test helps match blood transfusions to patients with sickle cell disease
I told my high school friend we'd battle sickle cell together. But she didn't make it past 18
Sickle cell disease is a common inherited disorder in Kenya, affecting millions globally.